WEBINAR - 4 WAYS TO IMPLEMENT NGS LIQUID BIOPSIES- WITHOUT UMI
Our CTO, Dr. Cristian Ionescu-Zanetti, presented this webinar on Thursday, August 1. The webinar...
FLUXION BIOSCIENCES JOINS BLOODPAC CONSORTIUM TO ACCELERATE LIQUID BIOPSY DEVELOPMENT
Participation will help advance liquid biopsy adoption by collaborating among key industry...
GLYCOCALYX RESEARCH ACCELERATES WITH THE BIOFLUX SYSTEM
Glycocalyx research utilizing the BioFlux System
RECENT PUBLICATIONS VALIDATE FLUXION'S LIQUID BIOPSY TECHNOLOGIES
Publications demonstrate depth and breadth of Fluxion’s liquid biopsy technologies
FLUXION BIOSCIENCES RECEIVES NATIONAL CANCER INSTITUTE GRANT FOR DEVELOPMENT OF ERASE-SEQ LIQUID BIOPSY TECHNOLOGY
Grant will support advanced development and clinical validation with researchers at Cleveland Clinic
FLUXION BIOSCIENCES LAUNCHES CUSTOM LIQUID BIOPSY NGS PANEL DEVELOPMENT
Custom panels can be now be validated and analyzed using ERASE-Seq variant caller
NEW DATA DEMONSTRATES SUPERIOR ACCURACY OF FLUXION’S ERASE-SEQ VARIANT CALLER FOR LIQUID BIOPSIES
Inter-sample digital processing improves sensitivity and specificity of variant calling; results...